Cargando…

A combined physiologically‐based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease

Antibody‐mediated removal of aggregated β‐amyloid (Aβ) is the current, most clinically advanced potential disease‐modifying treatment approach for Alzheimer's disease. We describe a quantitative systems pharmacology (QSP) approach of the dynamics of Aβ monomers, oligomers, protofibrils, and pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geerts, Hugo, Walker, Mike, Rose, Rachel, Bergeler, Silke, van der Graaf, Piet H., Schuck, Edgar, Koyama, Akihiko, Yasuda, Sanae, Hussein, Ziad, Reyderman, Larisa, Swanson, Chad, Cabal, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088087/ https://www.ncbi.nlm.nih.gov/pubmed/36632701 http://dx.doi.org/10.1002/psp4.12912

Ejemplares similares

Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease
por: Hayato, Seiichi, et al.
Publicado: (2022)

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model
por: Geerts, Hugo, et al.
Publicado: (2023)

Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study
por: Hussein, Ziad, et al.
Publicado: (2022)

Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
por: McDade, Eric, et al.
Publicado: (2022)

Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
por: Shiba, Sari, et al.
Publicado: (2020)

A modeling informed quantitative approach to salvage clinical trials interrupted due to COVID‐19
por: Geerts, Hugo, et al.
Publicado: (2020)

A discrete mathematical model for the aggregation of β-Amyloid
por: Dayeh, Maher A., et al.
Publicado: (2018)

Trehalose Effect on The Aggregation of Model Proteins into Amyloid Fibrils
por: Mari, Eleonora, et al.
Publicado: (2020)

Evaluation of the amyloid beta-GFP fusion protein as a model of amyloid beta peptides-mediated aggregation: a study of DNAJB6 chaperone
por: Hussein, Rasha M., et al.
Publicado: (2015)

Regulation of Pom cluster dynamics in Myxococcus xanthus
por: Bergeler, Silke, et al.
Publicado: (2018)

Changes in perampanel levels during de‐induction: Simulations following carbamazepine discontinuation
por: Schuck, Edgar, et al.
Publicado: (2020)

Modeling of chemical inhibition from amyloid protein aggregation kinetics
por: Vázquez, José Antonio
Publicado: (2014)

Zinc binding regulates amyloid-like aggregation of GAPR-1
por: Sheng, Jie, et al.
Publicado: (2019)

ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease
por: Honig, Lawrence S., et al.
Publicado: (2023)

Amyloids and protein aggregation
por: Linse, Sara, et al.
Publicado: (2023)

Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems
por: Florio, Daniele, et al.
Publicado: (2019)

Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases
por: Long, Houfang, et al.
Publicado: (2022)

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
por: Swanson, Chad J., et al.
Publicado: (2021)

Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
por: Swanson, Chad J., et al.
Publicado: (2022)

Deep phenotyping reveals movement phenotypes in mouse neurodevelopmental models
por: Klibaite, Ugne, et al.
Publicado: (2022)

Metal ions and redox balance regulate distinct amyloid-like aggregation pathways of GAPR-1
por: Sheng, Jie, et al.
Publicado: (2019)

Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy
por: Endo, Yoshinori, et al.
Publicado: (2019)

Drosophila Melanogaster as a Model System for Studies of Islet Amyloid Polypeptide Aggregation
por: Schultz, Sebastian Wolfgang, et al.
Publicado: (2011)

A Simple Lattice Model That Captures Protein Folding, Aggregation and Amyloid Formation
por: Abeln, Sanne, et al.
Publicado: (2014)

An Efficient Kinetic Model for Assemblies of Amyloid Fibrils and Its Application to Polyglutamine Aggregation
por: Prigent, Stéphanie, et al.
Publicado: (2012)

A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
por: Shammas, Sarah L., et al.
Publicado: (2015)

Misfolding and Amyloid Aggregation of Apomyoglobin
por: Iannuzzi, Clara, et al.
Publicado: (2013)

The yin and yang of amyloid aggregation
por: Falsone, S Fabio
Publicado: (2015)

Structure and Aggregation Mechanisms in Amyloids
por: L. Almeida, Zaida, et al.
Publicado: (2020)

Natural Inhibitors of Amyloid Aggregation
por: Tortora, Paolo, et al.
Publicado: (2023)

Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant
por: Dayal, Satish, et al.
Publicado: (2021)

Amyloid β aggregation inhibitory activity of triterpene saponins from the cactus Stenocereus pruinosus
por: Fujihara, Koji, et al.
Publicado: (2020)

Amyloid β-Sheet Mimics that Antagonize Amyloid Aggregation and Reduce Amyloid Toxicity
por: Cheng, Pin-Nan, et al.
Publicado: (2012)

Effect of gastric acid‐reducing agents on the pharmacokinetics and efficacy of lemborexant
por: Landry, Ishani, et al.
Publicado: (2020)

Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant
por: Landry, Ishani, et al.
Publicado: (2021)

Aryloxypropanolamine targets amyloid aggregates and reverses Alzheimer-like phenotypes in Alzheimer mouse models
por: Lee, Hee Yang, et al.
Publicado: (2022)

Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
por: Kumari, Anchala, et al.
Publicado: (2020)

Age-Dependent Protein Aggregation Initiates Amyloid-β Aggregation
por: Groh, Nicole, et al.
Publicado: (2017)

Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors
por: Ueno, Takashi, et al.
Publicado: (2021)

Topological Data Analysis of Biological Aggregation Models
por: Topaz, Chad M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_up0v2jnfns8g8bq3ocj3b66iea